Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Non-Current Debt (2023 - 2026)

Cannabis Bioscience International Holdings' Non-Current Debt history spans 4 years, with the latest figure at $249500.0 for Q1 2026.

  • On a quarterly basis, Non-Current Debt changed 0.0% to $249500.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $249500.0, a 0.0% change, with the full-year FY2025 number at $249500.0, changed 0.06% from a year prior.
  • Non-Current Debt hit $249500.0 in Q1 2026 for Cannabis Bioscience International Holdings, roughly flat from $249500.0 in the prior quarter.
  • Over the last five years, Non-Current Debt for CBIH hit a ceiling of $249501.0 in Q1 2025 and a floor of $249361.0 in Q2 2024.
  • Historically, Non-Current Debt has averaged $249487.5 across 4 years, with a median of $249500.0 in 2023.
  • Biggest five-year swings in Non-Current Debt: fell 0.06% in 2024 and later grew 0.06% in 2025.
  • Tracing CBIH's Non-Current Debt over 4 years: stood at $249500.0 in 2023, then changed by 0.0% to $249500.0 in 2024, then changed by 0.0% to $249500.0 in 2025, then changed by 0.0% to $249500.0 in 2026.
  • Business Quant data shows Non-Current Debt for CBIH at $249500.0 in Q1 2026, $249500.0 in Q4 2025, and $249500.0 in Q3 2025.